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April 5, 2011:1568–71psychosocial factors such as clinical depression, hostility/anger, and
acute/chronic mental stress have cardiovascular risk gradients compa-
rable to or steeper than the risk gradients of more traditional risk
factors such as elevated cholesterol (2,4). Furthermore, it is well
known that emotional outbursts in asymptomatic but vulnerable
individuals can trigger acute coronary syndromes (7). We wonder
what the reason is for such an omission in cardiovascular risk
stratification and primary prevention, and we call for recognition of
psychosocial factors because whatever physiologic or behavioral mecha-
nisms link them to the pathogenesis and expression of heart disease,
recognition and treatment of at least depression, hostility/anger, and
chronic psychologic stress may lead to cardiovascular risk reduction
throughmodification of the adverse physiologic and behavioral correlates.
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Guidelines for Assessment
of Cardiovascular Disease
in Life Insurance
The Task Force that prepared the 2010 American College of
Cardiology Foundation/American Heart Association Guidelines
for Assessment of Cardiovascular Risk in Asymptomatic Adults
(1) included representatives of societies of echocardiography,
nuclear cardiology, imaging, angiography, computed tomography,
and cardiovascular magnetic resonance imaging. It is surprisingthat there were no representatives of the group with the greatest
experience and professional interest in the subject—physicians and
cardiologists in the life insurance industry. This industry was the
first to accept the importance of brachial cuff blood pressure as a
measure of risk in 1917 and the first to use radial artery tonometry
and pulse waveform analysis to reject applicants for life insurance
even earlier (2).
It is surprising too that the views of the task force with respect
to aortic stiffness and pulse wave analysis conflict with those of the
European Societies of Hypertension and of Cardiology (3), which
see the value of such measurements for the prediction of risk. The
European societies considered mechanism and history in prepara-
tion of their guidelines, whereas the U.S. task force did not—they
concentrated on evidence available up to 2009/2010 from identi-
fication of “key words.” However, none of the key words that relate
to arterial aging were considered, not even such basic words as
“aging,” “aortic stiffness,” “pulse wave analyses,” “pulse wave
velocity,” “wave reflection,” or “tonometry.” If the key words are
not sought, the “evidence” will not be available.
There are multiple prospective studies (4–6) that justify a Level of
vidence: A rather than a Level of Evidence: C, including meta-
nalyses presented by Roman (7) and by Vlachopoulos et al. (5,6).
The purpose of the life insurance industry is to provide the
ommunity with life coverage on the basis of the best risk
nformation available. Tests that can be done to stratify risk cannot
e invasive or involve radiation, must identify risk over and above
onventional risk factors, and must be inexpensive. Pulse wave
elocity and pulse waveform analysis appear to provide such
nformation. We would be grateful if this issue could be reconsid-
red because it applies to the global life insurance industry, which
ooks to the American College of Cardiology Foundation and the
merican Heart Association for leadership and guidance.
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Reply
The American College of Cardiology Foundation (ACCF)/
American Heart Association (AHA) welcomes letters to inform
its ongoing work and encourages such correspondence about its
guidelines. Because the ACCF/AHA guideline development
process is rigorous and involves several layers of review by the
writing committee, external peer reviewers, and participating
organizations in the document, the ACCF/AHA cannot re- Pspond to each issue raised after a guideline has been published.
The information, however, is forwarded to the writing commit-
tee chair and oversight task force for review. If any issue is
deemed by the ACCF/AHA to affect patient safety, it will be
considered immediately. Otherwise, the information will be
considered during the next update or revision of the guideline.
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